fda warning letters glp-1 september 2025 There's lots going on this month at in the world of weight loss drugs. The agency is taking a hard look at the market. Check out these new #FDA Trends In FDA FY 2025

Many individuals experience improved sleep quality and feel more energized upon waking

Malinda et.al, Thymosin 4 Accelerates Wound Healing, Journal of Investigative Dermatology, Volume 113, Issue 3, 1999, Pages 364-368, ISSN 0022-202X, Study of Thymosin Beta 4 in Patients With Pressure Ulcers

Retatrutide is being studied for: Type 2 diabetes MASH(Metabolic Dysfunction-Associated Steatohepatitis), a liver condition caused by fat buildup Heart disease risk reduction Knee osteoarthritis in people with higher body weight More research is needed before doctors know whether retatrutide is safe and effective for these conditions

They come from hormone changes that shift how your body stores fat, regulates appetite, and burns calories

Association between smoking and risk of primary biliary cholangitis: a systematic review and meta-analysis

Among fat loss peptides specifically, AOD 9604 stands out for having the most extensive human safety data from controlled trials